Thromboembolic and Bleeding Events in COVID-19 Patients receiving Extracorporeal Membrane Oxygenation.

Koray DurakAlexander KerstenOliver GrottkeRachad ZayatMichael DreherRüdiger AutschbachGernot MarxNikolaus MarxJan SpillnerSebastian Kalverkamp

Published in: The Thoracic and cardiovascular surgeon (2021)

This study describes the incidences of TEE and BE in critically ill COVID-19 patients treated with ECMO. The most common adverse event during ECMO support was bleeding, which occurred at a comparable rate to non-COVID-19 patients treated with ECMO.

Keyphrases

extracorporeal membrane oxygenation
coronavirus disease
acute respiratory distress syndrome
sars cov
respiratory failure
atrial fibrillation
respiratory syndrome coronavirus
mechanical ventilation
emergency department
intensive care unit